Drug · DIN 02468816
IMFINZI
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 20, 2017; first marketed November 20, 2017.
- Drug Identification Number (DIN)
- 02468816
- Company (DIN owner)
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Durvalumab L01FF03
- Class
- Human
- Record last updated
- September 11, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DURVALUMAB | 50 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 3, 2017: NOC 20026New Drug Submission (NDS)